| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |